Zurcher Kantonalbank (Zurich Cantonalbank) - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 256 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$177,405
-7.2%
38,990
+43.6%
0.00%0.0%
Q2 2023$191,206
+112.0%
27,160
+84.0%
0.00%
Q1 2023$90,190
-4.4%
14,7610.0%0.00%
-100.0%
Q4 2022$94,323
-33.1%
14,7610.0%0.00%0.0%
Q3 2022$141,000
-13.5%
14,7610.0%0.00%0.0%
Q2 2022$163,000
-46.4%
14,761
-19.1%
0.00%0.0%
Q1 2022$304,000
-17.8%
18,247
-6.0%
0.00%
-50.0%
Q4 2021$370,000
+13.8%
19,408
+47.1%
0.00%0.0%
Q3 2021$325,000
-5.2%
13,191
-0.0%
0.00%0.0%
Q2 2021$343,000
-17.5%
13,197
+0.5%
0.00%0.0%
Q1 2021$416,000
-35.4%
13,136
-5.4%
0.00%
-50.0%
Q4 2020$644,000
+63.5%
13,883
+16.1%
0.00%
+33.3%
Q3 2020$394,000
+30.9%
11,959
+9.1%
0.00%0.0%
Q2 2020$301,000
+8.3%
10,957
+18.0%
0.00%0.0%
Q1 2020$278,000
+26.4%
9,285
+16.7%
0.00%
+50.0%
Q4 2019$220,000
+30.2%
7,953
-14.6%
0.00%
+100.0%
Q3 2019$169,000
-25.9%
9,3130.0%0.00%
-50.0%
Q2 2019$228,000
+88.4%
9,313
-26.8%
0.00%
+100.0%
Q1 2019$121,000
+7.1%
12,7180.0%0.00%0.0%
Q4 2018$113,000
-28.0%
12,718
-8.6%
0.00%0.0%
Q3 2018$157,000
-11.8%
13,9180.0%0.00%
-50.0%
Q2 2018$178,000
+22.8%
13,918
+61.8%
0.00%
+100.0%
Q1 2018$145,0008,6000.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 3,876,600$127,618,00011.48%
Fairmount Funds Management LLC 596,890$19,650,0008.32%
Ghost Tree Capital, LLC 575,000$18,929,0005.47%
Perceptive Advisors 10,085,632$332,019,0004.85%
Avoro Capital Advisors LLC 9,536,039$313,926,0004.46%
FRAZIER MANAGEMENT LLC 1,312,999$43,224,0003.88%
ACUTA CAPITAL PARTNERS, LLC 315,000$10,370,0002.82%
Orbimed Advisors 6,645,100$218,757,0002.75%
QVT Financial LP 572,971$18,862,0002.30%
Prosight Management, LP 120,606$3,970,0001.89%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders